Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.
Ontology highlight
ABSTRACT: Alopecia is a dermatological condition with limited therapeutic options. Only two drugs, finasteride and minoxidil, are approved by FDA for alopecia treatment. However, little is known about the differences in adverse effects between these two drugs. We examined the clinical reports submitted to the FDA Adverse Event Reporting System (FAERS) from 2004 to 2014. For both female and males, finasteride was found to be more associated with reproductive toxicity as compared to minoxidil. Among male alopecia cases, finasteride was significantly more concurrent with several forms of sexual dysfunction. Among female alopecia cases, finasteride was significantly more concurrent with harm to fetus and disorder of uterus. In addition, drug-gene network analysis indicated that finasteride could profoun
SUBMITTER: Wu M
PROVIDER: S-EPMC5347675 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA